StockData
Scinai Immunotherapeutics Ltd. logo

Scinai Immunotherapeutics Ltd. (SCNI) stock

SCNINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 6/30
$0.37−0.03 (-7.82%)

Close on Nov 17, 2026Market cap $1.29MP/E –Yield –

Scinai Immunotherapeutics EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

For fiscal 2023 it was $0.00, down 60.0% from the year before. The highest annual figure on record is $0.01 in fiscal 2022.

Annual eps

PeriodPeriod endValueChange
FY2023Dec 31, 2023$0.00-60.0%
FY2022Dec 31, 2022$0.01–
FY2021Dec 31, 2021-$0.02–
FY2019Dec 31, 2019-$0.33–
FY2017Dec 31, 2017-$0.05–

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2023Jun 30, 2023-$0.00-103.0%
Q1 FY2023Mar 31, 2023-$0.00–
Q2 FY2022Jun 30, 2022-$0.00–
Q1 FY2022Mar 31, 2022-$0.00–
Q3 FY2020Sep 30, 2020$0.10–
Q3 FY2019Sep 30, 2019-$0.05–

More Scinai Immunotherapeutics figures

See a number that looks wrong?